Melbourne, Australia, 23 November 2015: Two new Victorian medical technology companies have been awarded $9 million in venture capital funding to develop novel treatments for heart failure and peanut allergies. The companies, Cardiora Pty Ltd and Aravax Pty Ltd -- spun out of the Baker IDI Heart and Diabetes Institute and Alfred Health and Monash University respectively – have secured vital venture capital support from the Brandon Capital managed Medical Research Commercialisation Fund (MRCF), which has State Government backing and was established in 2007 to promote the creation of early stage medical technology companies. Under the latest funding program Cardiora will today officially recei